For MYH10, It was found that combining FAK inhibitors with MAPK inhibitors or CDK4/6 inhibitors may be associated with drug resistance and prognosis in ovarian cancer (67), etc. The current study revealed for the first time that this gene may be related to the prognosis of gastric cancer. This evidence concerns the gene PTK2 and ovarian carcinoma.